PharmAthene - Dedicated to a Safer World
HomeAbout UsInvestor RelationsContact UsLinksSite MapEmployment Opportunities.gif
Welcome to PharmAtheneBio-Chem Defense
Solution: Our Products
News Releases
Shareholder Information


Analyst Coverage

To the best of its knowledge, PharmAthene, Inc. is followed by the analysts listed below:

FirmAnalystPhoneE-Mail
Rodman & Renshaw Elemer  Piros, Ph.D212-430-1754epiros@rodm.com
BDR Research Group, LLCMatt Duffy212-994-3774duffy@bdrllc.com
Crystal Equity ResearchDebra Fiakas, CFA212-400-7519 dfiakas@crystalequityresearch.com
WBB SecuritiesDaniel Mallin, Ph.D.908-518-7610 dmallin@wbbsec.com
Noble FinancialRaghuram Selvaraju, Ph.D.212-497-4004
ROTH Capital Partners Joseph Pantginis, PhD646-358-1907

It is important to note that any opinions, estimates or forecasts regarding PharmAthene, Inc.'s performance and any conclusions or recommendations made by these analysts are theirs alone and do not represent opinions, estimates, forecasts, conclusions or recommendations of PharmAthene, Inc. or its management. By providing the list above, PharmAthene, Inc. does not imply its endorsement or approval of, or concurrence with, such opinions, estimates, forecasts, conclusions or recommendations. The list includes analysts currently known by PharmAthene, Inc. to follow the company, but may not be complete and may change as firms add or delete coverage. PharmAthene, Inc. updates the list periodically, but undertakes no obligation to do so. Copies of the reports by any of the listed analysts must be obtained directly from the analysts or their firms. PharmAthene, Inc. does not distribute such reports. The information contained on, accessible through or referenced on this webpage does not constitute an offer to sell nor a solicitation of an offer to buy securities of PharmAthene, Inc. or its affiliates in the United States or in any other jurisdiction.

Privacy StatementTerms & ConditionsEmployment Opportunities